ReviewFood chemistry: X2026
Artificial intelligence in functional food innovation: Bioactive enhancement and formulation optimization: A quasi-systematic review.
Review in Food chemistry: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Valorization of Food Industry By-Products for Sustainable Functional Food Production: Recent Advances and Future Perspectives.Foods (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is increasingly integrated into functional food research. This quasi-systematic review analyzes 53 peer-reviewed studies (2015-2025) to outline current applications and emerging directions, including the underexplored domain of antioxidant food development. The review attempts to provide an updated synthesis of AI approaches across compound discovery, metabolomics, and consumer modeling, emphasizing knowledge gaps and opportunities for methodological integration. Data-driven AI (classical machine learning) and deep learning methods have been applied to predict antioxidant activity, identify bioactive compounds, and reveal patterns in metabolomic data. Unsupervised approaches have assisted in clustering complex datasets, whereas optimization algorithms supported the adjustment of sensory, nutritional, and functional attributes. However, many current systems remain limited to
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.